On July 1, Definium Therapeutics fell 5.02% in regular trading, trading at $44.52 USD/share, with Turnover of $43.21 million.
Within the Pharmacy sector where Definium Therapeutics belongs, among individual stocks, Eli Lilly down 0.61%, Johnson & Johnson down 0.61%, Pfizer down 0.69%, Merck down 1.44%, Novo-Nordisk up 2.65%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)